List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its ...

Five9 (FIVN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Large Cap financials underperformed for much of the last two years The biggest banks also have strong brokerage units ...

Sales were up 6% year over year in the fiscal 2025 second quarter (ended Sept. 30), reversing the year-ago quarter's 8% ...

Despite relatively high valuations, few high-quality stocks have sold off recently. Click here for 3 'must-buy' growth stocks ...

A Buy rating for ... at Asia Value & Moat Stocks. Learn More » UP Fintech disclosed its performance for the third quarter of ...

If a stock hits a 10-year low, there's little doubt that buying it involves taking on some considerable risk. For that kind ...

The semiconductor sector has more than rebounded from some volatility earlier this year, with the SOXX index making some ...

Looking ahead, Dutch Bros once again raised its full-year forecast. It is now guiding for revenue of between $1.255 billion ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...